E-LIB Suche - Ergebnisse für: Gasparoli, Luca

1

Identification of a c-MYB-directed therapeutic for acute my..:

Clesham, Katherine ; Walf-Vorderwülbecke, Vanessa ; Gasparoli, Luca...
Leukemia. 36 (2022) 6 - p. 1541-1549 , 2022

Link: https://doi.org/10.1038/..

2

Direct targeted therapy for MLL‐fusion‐driven high‐risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
Clinical and Translational Medicine. 12 (2022) 6 - p. , 2022

Link: https://doi.org/10.1002/..

3

ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21..:

Virely, Clemence ; Gasparoli, Luca ; Mangolini, Maurizio...
HemaSphere. 4 (2020) 5 - p. , 2020

Link: https://doi.org/10.1097/..

4

The AAA+ATPase RUVBL2 is essential for the oncogenic functi..:

Armenteros-Monterroso, Elena ; Zhao, Lu ; Gasparoli, Luca...
Leukemia. 33 (2019) 12 - p. 2817-2829 , 2019

Link: https://doi.org/10.1038/..

5

The combined activation of KCa3.1 and inhibition of Kv11.1/..:

Pillozzi, Serena ; D'Amico, Massimo ; Bartoli, Gianluca...
British Journal of Cancer. 118 (2017) 2 - p. 200-212 , 2017

Link: https://doi.org/10.1038/..

6

NAMI-A is highly cytotoxic toward leukaemia cell lines: evi..:

Pillozzi, Serena ; Gasparoli, Luca ; Stefanini, Matteo...
Dalton Trans.. 43 (2014) 32 - p. 12150-12155 , 2014

Link: https://doi.org/10.1039/..

7

hERG1 channels modulate integrin signaling to trigger angio..:

Crociani, Olivia ; Zanieri, Francesca ; Pillozzi, Serena...
Scientific Reports. 3 (2013) 1 - p. , 2013

Link: https://doi.org/10.1038/..

8

Susceptibility of pediatric acute lymphoblastic leukemia to..:

Gasparoli, Luca ; Virely, Clemence ; Tsakaneli, Alexia...
https://discovery.ucl.ac.uk/id/eprint/10178557/7/Williams_Susceptibility%20of%20pediatric%20acute%20lymphoblastic%20leukemia%20to%20STAT3%20inhibition%20depends%20on%20p53%20induction_VoR.pdf. , 2023

Link: https://discovery.ucl.ac..

9

Identification of a c-MYB-directed therapeutic for acute my..:

Clesham, Katherine ; Walf-Vorderwülbecke, Vanessa ; Gasparoli, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162920/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Direct targeted therapy for MLL-fusion-driven high-risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
https://www.repository.cam.ac.uk/handle/1810/339424. , 2022

Link: https://www.repository.c..

11

Identification of a c-MYB-directed therapeutic for acute my..:

Clesham, Katherine ; Walf-Vorderwülbecke, Vanessa ; Gasparoli, Luca...
Clesham , K , Walf-Vorderwülbecke , V , Gasparoli , L , Virely , C , Cantilena , S , Tsakaneli , A , Inglott , S , Adams , S , Samarasinghe , S , Bartram , J , Williams , G , de Boer , J & Williams , O 2022 , ' Identification of a c-MYB-directed therapeutic for acute myeloid leukemia ' , Leukemia , vol. 36 , no. 6 , pp. 1541-1549 . https://doi.org/10.1038/s41375-022-01554-9. , 2022

Link: https://kclpure.kcl.ac.u..

12

Direct targeted therapy for MLL‐fusion‐driven high‐risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214753/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Direct targeted therapy for MLL-fusion-driven high-risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
https://www.repository.cam.ac.uk/handle/1810/337999. , 2022

Link: https://www.repository.c..

14

Direct targeted therapy for MLL‐fusion‐driven high‐risk acu..:

Cantilena, Sandra ; Gasparoli, Luca ; Pal, Deepali...
https://nrl.northumbria.ac.uk/id/eprint/49596/1/Clinical%20%20%20Translational%20Med%20-%202022%20-%20Cantilena%20-%20Direct%20targeted%20therapy%20for%20MLL%E2%80%90fusion%E2%80%90driven%20high%E2%80%90risk%20acute%20leukaemias.pdf. , 2022

Link: https://nrl.northumbria...

15

Identification of a c-MYB-directed therapeutic for acute my..:

Clesham, Katherine ; Walf-Vorderwülbecke, Vanessa ; Gasparoli, Luca...
https://discovery.ucl.ac.uk/id/eprint/10146706/1/s41375-022-01554-9.pdf. , 2022

Link: https://discovery.ucl.ac..